Investment
Features
FeesSafety
Academy
More
Pluang+

Central Asia Metals sees 46% revenue rise and nearly doubles earnings on higher metal prices and output

Company Fundamentals
26 Aug 2026
Proactive Investors
View Source
Bullish
pluang ai news

Central Asia Metals PLC reported a 46% increase in revenue to $145.5 million for the first half of the year, driven by higher copper and zinc prices and increased production. EBITDA nearly doubled to $75.5 million, with profit before tax up 203% to $59.3 million, and free cash flow almost tripled to $46.8 million. Production rose modestly across copper, zinc, and lead, while the company maintained its full-year production guidance. It also completed a $10 million share buyback and plans to finalize its $232 million acquisition of Cygnus Metals by early October.

More News

Top chip ETF averages 14% annual return since 2001, surging 118% in past year

Top chip ETF averages 14% annual return since 2001, surging 118% in past year

A leading semiconductor exchange-traded fund (ETF) has delivered an impressive average annual return of 14% since 2001. Over the last twelve months alone, the ETF surged by 118%, highlighting strong growth in the chip sector. This performance undersc...

Market News
Bullish
1 hour ago
Revolut launches EURR, a regulated euro-backed stablecoin, expanding its digital asset offerings in Europe.

Revolut launches EURR, a regulated euro-backed stablecoin, expanding its digital asset offerings in Europe.

Revolut has introduced EURR, a euro-pegged stablecoin issued under the EU's MiCA regulations through a Luxembourg-based entity owned by Stripe. Initially available to select customers in Denmark, Poland, and Portugal, EURR allows Revolut's 80 million...

Protocol Fundamentals
Bullish
4 hours ago
AllianceBernstein cuts Strategy price target to $350 but keeps outperform rating, sees Bitcoin hitting $300K by 2029.

AllianceBernstein cuts Strategy price target to $350 but keeps outperform rating, sees Bitcoin hitting $300K by 2029.

AllianceBernstein lowered its price target for Strategy (formerly MicroStrategy) from $450 to $350, citing equity dilution and a tougher interest rate environment. Despite the cut, the firm maintained an outperform rating, believing in the long-term ...

Analyst Insights
Neutral
4 hours ago
Jefferies raises Whitbread target price but keeps cautious 'hold' rating amid resilient UK hotel demand.

Jefferies raises Whitbread target price but keeps cautious 'hold' rating amid resilient UK hotel demand.

Jefferies has increased its price target for Whitbread PLC to 2,250p due to stronger-than-expected UK hotel revenue driven by solid forward bookings. Despite this, the broker maintains a cautious 'hold' rating, noting that the current valuation alrea...

Analyst Insights
Neutral
4 hours ago
Faron Pharmaceuticals secures funding to advance key BEXERA trial with strong interim data.

Faron Pharmaceuticals secures funding to advance key BEXERA trial with strong interim data.

Faron Pharmaceuticals has raised its cash reserves to €32 million, extending its financial runway to November 2027, enabling continued progress on its BEXERA trial for high-risk myelodysplastic syndrome. The phase IIb trial will start in late 2026, t...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App